Skip to main content
Top

Open Access 13-05-2025 | Disease of Central Nervous System | Teaching Case Presentations

Association of type 1 stiff-person syndrome and insulinoma: a case report and narrative review

Authors: Michela Sibilla, Guglielmo Beccuti, Sara Belcastro, Umberto Mortara, Simone Parisi, Donata Campra, Alessandro Piovesan, Bruno Ferrero, Mauro Maccario, Mauro Papotti, Alessandro Maria Berton

Published in: Hormones

Login to get access

Abstract

Introduction

Stiff-person syndrome (SPS) is a rare neurological disorder that causes progressive muscle rigidity, gait disturbances, and functional impairment; type 1 is autoimmune, with positive anti-GAD antibodies (Ab), while type 2 is paraneoplastic and associated with antiamphiphysin Ab.

Case presentation

A 41-year-old man with a silent medical history presented with stiffness and functional impairment; after numerous rheumatological and neurological investigations, he was diagnosed with SPS, with evidence of high titer anti-GAD Ab. After treatment with benzodiazepines was started, the patient began to experience episodes of confusion, which persisted even after reducing the dosage. During one of these episodes, he was admitted to the emergency department and a glucose level of 26 mg/dL was found. Differential diagnosis led to detection of an insulin-secreting neuroendocrine tumor of the pancreas; thus, a paraneoplastic origin of SPS was hypothesized. However, antiamphiphysin Ab were negative, anti-GAD Ab were persistently elevated, and symptoms only transiently improved after removal of the tumor.

Conclusion

This is the first case, to our knowledge, demonstrating association between type 1 SPS and insulinoma, along with describing partial and transient improvement of neurological symptoms after resolution of the associated hypoglycemic syndrome.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Association of type 1 stiff-person syndrome and insulinoma: a case report and narrative review
Authors
Michela Sibilla
Guglielmo Beccuti
Sara Belcastro
Umberto Mortara
Simone Parisi
Donata Campra
Alessandro Piovesan
Bruno Ferrero
Mauro Maccario
Mauro Papotti
Alessandro Maria Berton
Publication date
13-05-2025
Publisher
Springer International Publishing
Published in
Hormones
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.1007/s42000-025-00666-y

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more